{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:45Z","timestamp":1790400165859,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10549-010-1095-5","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T00:50:58Z","timestamp":1281315058000},"page":"857-861","source":"Crossref","is-referenced-by-count":38,"title":["Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer"],"prefix":"10.1007","volume":"124","author":[{"given":"Yonglan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisha","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezheng","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"issue":"12","key":"1095_CR1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with brca1 and brca2 in diverse populations. Nat Rev Cancer 7(12):937\u2013948. doi: 10.1038\/nrc2054","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1095_CR2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/bgi136","volume":"26","author":"HM Sowter","year":"2005","unstructured":"Sowter HM, Ashworth A (2005) Brca1 and brca2 as ovarian cancer susceptibility genes. Carcinogenesis 26(10):1651\u20131656. doi: 10.1093\/carcin\/bgi136","journal-title":"Carcinogenesis"},{"issue":"2","key":"1095_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N (2007) Biallelic mutations in palb2 cause Fanconi anemia subtype fa-n and predispose to childhood cancer. Nat Genet 39(2):162\u2013164. doi: 10.1038\/ng1947","journal-title":"Nat Genet"},{"issue":"2","key":"1095_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the brca2 partner palb2. Nat Genet 39(2):159\u2013161. doi: 10.1038\/ng1942","journal-title":"Nat Genet"},{"issue":"5","key":"1095_CR5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","volume":"42","author":"F Vaz","year":"2010","unstructured":"Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG (2010) Mutation of the rad51c gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406\u2013409. doi: 10.1038\/ng.570","journal-title":"Nat Genet"},{"issue":"5","key":"1095_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish rad51c as a human cancer susceptibility gene. Nat Genet 42(5):410\u2013414. doi: 10.1038\/ng.569","journal-title":"Nat Genet"},{"issue":"2","key":"1095_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1101\/gr.080259.108","volume":"19","author":"OA Hampton","year":"2009","unstructured":"Hampton OA, Den Hollander P, Miller CA, Delgado DA, Li J, Coarfa C, Harris RA, Richards S, Scherer SE, Muzny DM, Gibbs RA, Lee AV, Milosavljevic A (2009) A sequence-level map of chromosomal breakpoints in the mcf-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 19(2):167\u2013177. doi: 10.1101\/gr.080259.108","journal-title":"Genome Res"},{"issue":"20","key":"1095_CR8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","volume":"362","author":"AD D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea AD (2010) Susceptibility pathways in Fanconi\u2019s anemia and breast cancer. N Engl J Med 362(20):1909\u20131919. doi: 10.1056\/NEJMra0809889","journal-title":"N Engl J Med"},{"issue":"6","key":"1095_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","volume":"2","author":"H Joenje","year":"2001","unstructured":"Joenje H, Patel KJ (2001) The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet 2(6):446\u2013457. doi: 10.1038\/3507659035076590","journal-title":"Nat Rev Genet"},{"issue":"10","key":"1095_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrg2159","volume":"8","author":"W Wang","year":"2007","unstructured":"Wang W (2007) Emergence of a DNA-damage response network consisting of Fanconi anemia and brca proteins. Nat Rev Genet 8(10):735\u2013748. doi: 10.1038\/nrg2159","journal-title":"Nat Rev Genet"},{"key":"1095_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","volume":"43","author":"GL Moldovan","year":"2009","unstructured":"Moldovan GL, D\u2019Andrea AD (2009) How the Fanconi anemia pathway guards the genome. Annu Rev Genet 43:223\u2013249. doi: 10.1146\/annurev-genet-102108-134222","journal-title":"Annu Rev Genet"},{"issue":"19","key":"1095_CR12","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1158\/0008-5472.CAN-07-1501","volume":"67","author":"M Berwick","year":"2007","unstructured":"Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD (2007) Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res 67(19):9591\u20139596. doi: 10.1158\/0008-5472.CAN-07-1501","journal-title":"Cancer Res"},{"issue":"19","key":"1095_CR13","first-page":"5340","volume":"60","author":"M Barlund","year":"2000","unstructured":"Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G, Kallioniemi O-P, Kallioniemi A (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 60(19):5340\u20135344","journal-title":"Cancer Res"},{"issue":"19","key":"1095_CR14","first-page":"5371","volume":"60","author":"GJ Wu","year":"2000","unstructured":"Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ (2000) 17q23 amplifications in breast cancer involve the pat1, rad51c, ps6k, and sigma1b genes. Cancer Res 60(19):5371\u20135375","journal-title":"Cancer Res"},{"issue":"22","key":"1095_CR15","doi-asserted-by":"crossref","first-page":"19322","DOI":"10.1074\/jbc.M201402200","volume":"277","author":"CA French","year":"2002","unstructured":"French CA, Masson JY, Griffin CS, O\u2019Regan P, West SC, Thacker J (2002) Role of mammalian rad51l2 (rad51c) in recombination and genetic stability. J Biol Chem 277(22):19322\u201319330. doi: 10.1074\/jbc.M201402200M201402200","journal-title":"J Biol Chem"},{"issue":"2","key":"1095_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2004.08.018","volume":"219","author":"J Thacker","year":"2005","unstructured":"Thacker J (2005) The rad51 gene family, genetic instability and cancer. Cancer Lett 219(2):125\u2013135. doi: 10.1016\/j.canlet.2004.08.018","journal-title":"Cancer Lett"},{"key":"1095_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1747-1028-2-15","volume":"2","author":"SK Sharan","year":"2007","unstructured":"Sharan SK, Kuznetsov SG (2007) Resolving rad51c function in late stages of homologous recombination. Cell Div 2:15. doi: 10.1186\/1747-1028-2-15","journal-title":"Cell Div"},{"issue":"4","key":"1095_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.200811079","volume":"185","author":"S Badie","year":"2009","unstructured":"Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M (2009) Rad51c facilitates checkpoint signaling by promoting chk2 phosphorylation. J Cell Biol 185(4):587\u2013600. doi: 10.1083\/jcb.200811079","journal-title":"J Cell Biol"},{"issue":"1\u20132","key":"1095_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mrfmmm.2010.05.001","volume":"689","author":"G Smeenk","year":"2010","unstructured":"Smeenk G, de Groot AJ, Romeijn RJ, van Buul PP, Zdzienicka MZ, Mullenders LH, Pastink A, Godthelp BC (2010) Rad51c is essential for embryonic development and haploinsufficiency causes increased DNA damage sensitivity and genomic instability. Mutat Res 689(1\u20132):50\u201358. doi: 10.1016\/j.mrfmmm.2010.05.001","journal-title":"Mutat Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1095-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1095-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:32:36Z","timestamp":1559219556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1095-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1095-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}